background
exist
standard
nonmolecular
diagnost
method
viral
cultur
immunofluoresc
dfa
timeconsum
labor
intens
limit
sensit
sever
multiplex
molecular
assay
costli
therefor
need
develop
rapid
sensit
diagnosi
respiratori
viral
pathogen
method
gexpbas
multiplex
rtpcr
assay
gexp
assay
develop
detect
simultan
sixteen
differ
respiratori
viru
typessubtyp
seventeen
set
chimer
primer
use
initi
rtpcr
one
pair
univers
primer
use
subsequ
cycl
rtpcr
specif
gexp
assay
examin
posit
control
viru
typesubtyp
sensit
evalu
perform
assay
serial
tenfold
dilut
vitrotranscrib
rna
rna
virus
plasmid
contain
adv
hbov
target
sequenc
gexp
assay
evalu
use
clinic
specimen
compar
luminex
xtag
rvp
fast
assay
result
gexp
assay
achiev
sensit
copi
singl
viru
copi
premix
viral
target
present
analys
clinic
specimen
use
gexp
assay
demonstr
gexp
assay
rvp
fast
assay
complet
agreement
specimen
gexp
assay
sensit
rvp
fast
assay
detect
hrv
slightli
less
sensit
detect
hmpv
adv
rsvb
hbov
whole
process
gexp
assay
detect
sampl
complet
within
hour
conclus
conclus
gexp
assay
rapid
costeffect
sensit
specif
high
throughput
method
detect
respiratori
viru
infect
viral
respiratori
tract
infect
consider
morbid
fatal
rate
common
diseas
especi
affect
infant
elderli
common
respiratori
virus
includ
influenza
viru
influenza
b
viru
parainfluenza
viru
human
rhinoviru
adenoviru
respiratori
syncyti
viru
new
respiratori
virus
import
public
health
metapneumoviru
coronaviru
subtyp
sarscov
cov
human
bocaviru
emerg
past
decad
clinic
present
respiratori
infect
caus
differ
viral
pathogen
similar
make
etiolog
diagnosi
difficult
tradit
assay
use
diagnos
respiratori
tract
virus
viral
cultur
immunofluoresc
stain
viral
cultur
remain
gold
standard
diagnosi
respiratori
virus
broad
spectrum
high
specif
howev
viral
cultur
timeconsum
low
sensit
detect
respiratori
virus
fastidi
growth
requir
immunofluoresc
stain
fast
assay
sensit
avail
antisera
limit
factor
develop
rapid
molecular
techniqu
molecular
assay
especi
multiplex
format
accept
test
choic
broad
spectrum
detect
respiratori
virus
sever
multiplex
assay
avail
commerci
xtag
rvp
luminex
multicodeplx
rvp
eragen
bioscienc
resplex
ii
qiagen
howev
base
liquidphas
beadbas
array
technolog
implement
detect
increas
cost
implement
time
whole
assay
genomelab
gene
express
profil
genet
analysi
system
gexp
develop
beckman
coulter
brea
ca
usa
new
multitarget
highthroughput
detect
platform
integr
revers
transcriptionpcr
rtpcr
label
amplifi
product
multiplex
pcr
assay
follow
fluoresc
capillari
electrophoresi
separ
base
size
amplifi
product
system
use
previous
identifi
rapidli
gene
express
prostat
cancer
biomark
signatur
biolog
sampl
rapid
sensit
detect
uniqu
varicella
zoster
viru
gene
transcript
detect
pandem
influenza
viru
nine
serotyp
enterovirus
associ
hand
foot
mouth
diseas
report
novel
rtpcr
assay
use
gexp
gexp
assay
rapid
sensit
multiplex
detect
sixteen
differ
respiratori
viru
typessubtyp
influenza
viru
flua
influenza
b
viru
flub
season
influenza
viru
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
human
rhinoviru
hrv
human
metapneumoviru
hmpv
adenoviru
adv
respiratori
syncyti
viru
rsva
respiratori
syncyti
viru
b
rsvb
four
coronaviru
sybtyp
cov
cov
cov
cov
human
bocaviru
hbov
describ
specif
sensit
gexp
assay
examin
clinic
perform
gexp
assay
evalu
compar
result
obtain
gexp
assay
obtain
luminex
xtag
rvp
fast
kit
luminex
corpor
toronto
canada
nasopharyng
aspir
collect
hospit
children
cell
cultur
viru
stock
nattrol
tm
respiratori
valid
panel
zeptometrix
new
york
usa
use
posit
control
flua
flub
hrv
adv
rsva
rsvb
hmpv
cov
cov
clinic
specimen
genotyp
sequenc
previous
biotech
center
viral
diseas
emerg
part
chines
center
diseas
control
ccdc
use
posit
control
hbov
cov
cov
evalu
sensit
assay
control
prepar
dilut
copi
vector
contain
pcr
product
clone
viru
individu
pcr
product
clone
pgemt
vector
use
transform
cell
plasmid
dna
extract
ezna
plasmid
mini
kit
omega
ga
usa
rna
copi
number
calcul
measur
concentr
rna
transcrib
vitro
use
larg
scale
rna
product
system
promega
wisconsin
usa
dna
virus
adv
hbov
vitro
transcript
omit
total
nasopharyng
aspir
collect
children
two
year
age
hospit
children
hospit
beij
china
june
march
diagnosi
pneumon
bronchopneumonia
fever
greater
total
volum
ml
nasopharyng
aspir
collect
ml
transport
medium
studi
approv
beij
ethic
committe
sampl
collect
agre
child
parent
grandpar
inform
consent
total
pair
chimer
primer
one
pair
intern
control
primer
one
pair
univers
primer
design
rtpcr
chimer
primer
consist
genespecif
sequenc
fuse
end
univers
sequenc
specif
sequenc
select
align
sequenc
avail
viru
nation
center
biotechnolog
inform
ncbi
genbank
databas
primer
human
rnase
p
gene
use
intern
control
rtpcr
clinic
specimen
forward
univers
primer
end
sequenc
primer
sequenc
target
gene
size
result
amplicon
list
tabl
extract
purif
rnadna
total
rnadna
extract
viral
stock
clinic
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
extract
elut
dnaseand
rnasefre
water
store
multiplex
rtpcr
perform
one
step
rtpcr
kit
qiagen
hilden
germani
volum
contain
buffer
dntp
mix
enzym
mix
pmol
forward
chimer
primer
mix
revers
chimer
primer
mix
pmol
forward
univers
primer
mix
revers
univers
primer
mix
templat
rna
ribonucleas
inhibitor
takara
dalian
china
dnaseand
rnasefre
water
rtpcr
mixtur
subject
follow
amplif
condit
min
min
follow
primer
adv
f
adv
r
report
previous
primer
hbov
r
report
previous
univers
tag
sequenc
underlin
specif
gexp
assay
viral
target
test
individu
multiplex
assay
experiment
condit
gexp
assay
sensit
gexp
assay
viral
target
examin
individu
multiplex
assay
use
serial
tenfold
dilut
copi
vitrotranscrib
rna
rna
virus
plasmid
contain
adv
hbov
target
sequenc
sensit
gexp
assay
also
examin
use
premix
quantit
viral
target
luminex
xtag
rvp
fast
kit
luminex
corpor
toronto
canada
enabl
user
detect
simultan
flua
flub
rsv
adv
hmpv
cov
enteroviru
hrv
hbov
rnadna
extract
clinic
specimen
test
use
rvp
fast
assay
plate
format
accord
manufactur
instruct
luminex
corpor
toronto
canada
plate
analyz
use
bioplex
tm
system
biorad
ca
usa
accord
manufactur
instruct
median
fluoresc
intens
mfi
determin
specif
gexp
assay
viral
target
test
individu
multiplex
assay
misprim
observ
pair
chimer
primer
one
pair
intern
control
primer
mix
togeth
specif
product
could
obtain
separ
clearli
viral
target
gexp
system
posit
control
figur
ap
viral
target
use
clinic
specimen
posit
control
includ
hbov
cov
cov
singl
pcr
product
detect
addit
intern
control
peak
dye
signal
analysi
au
sensit
assay
evalu
individu
viru
multiplex
assay
use
serial
tenfold
dilut
clone
pcr
product
multiplex
assay
detect
level
hrv
copi
per
reaction
limit
detect
virus
typessubtyp
copi
per
reaction
clone
copi
viru
premix
evalu
sensit
viral
target
present
detect
sensit
premix
viral
target
copi
per
reaction
multiplex
assay
figur
r
specimen
detect
rvp
fast
assay
refer
method
retest
gexp
assay
result
assay
show
hrv
found
frequent
follow
rsvb
specimen
total
neg
specimen
detect
gexp
assay
neg
specimen
rvp
fast
assay
one
neg
specimen
detect
rvp
fast
assay
found
posit
hrv
gexp
assay
total
specimen
coinfect
detect
rvp
fast
assay
coinfect
detect
gexp
assay
addit
coinfect
detect
gexp
assay
confirm
sequenc
true
posit
result
gexp
assay
rvp
fast
assay
complet
agreement
specimen
shown
tabl
addit
virus
hrv
rsvb
hmpv
adv
hbov
specimen
found
rvp
fast
assay
virus
hrv
specimen
found
gexp
assay
addit
virus
detect
gexp
assay
confirm
sequenc
true
posit
result
show
gexp
assay
sensit
rvp
fast
assay
detect
hrv
less
sensit
detect
hmpv
adv
rsvb
hbov
rsva
cov
flua
flub
sensit
specif
sensit
specif
neg
predict
valu
npv
posit
predict
valu
ppv
viru
compar
rvp
fast
assay
refer
calcul
gexp
assay
tabl
see
figur
previou
page
figur
specif
sensit
analys
gexp
assay
yaxi
indic
dye
signal
arbitrari
unit
xaxi
indic
actual
pcr
product
size
panel
ap
show
result
amplif
flua
flub
flua
hrv
hmpv
adv
rsva
rsvb
hbov
cov
cov
cov
cov
respect
nucleasefre
water
use
neg
control
nc
premix
viral
target
could
detect
level
copi
viru
per
reaction
multiplex
assay
r
viral
target
left
right
hrv
rsva
flub
cov
cov
cov
hmpv
cov
flua
rsvb
hbov
adv
r
onestep
sensit
specif
assay
use
gexp
simultan
detect
respiratori
viru
typessubtyp
flua
flub
hrv
rsva
rsvb
hmpv
adv
cov
cov
cov
cov
hbov
describ
studi
gexp
genet
analysi
system
new
multitarget
high
throughput
detect
platform
applic
differenti
detect
pandem
influenza
viru
season
influenza
viru
report
recent
laboratori
reduc
assay
time
avoid
contamin
onestep
multitarget
rtpcr
perform
one
tube
rather
multiplex
twostep
rtpcr
separ
tube
would
prefer
develop
onestep
gexp
assay
sever
commerci
onestep
rtpcr
kit
differ
compani
omega
biorad
qiagen
invitrogen
test
preliminari
experi
onestep
rtpcr
kit
qiagen
reveal
best
amplif
perform
current
protocol
data
shown
temperatur
switch
pcr
tsp
strategi
adopt
optim
amplif
paramet
biphas
pcr
paramet
tsp
allow
multiplex
pcr
perform
standard
pcr
condit
therefor
requir
optim
individu
pcr
assay
optim
set
three
differ
denatur
temperatur
amplif
cycl
condit
determin
current
protocol
chimer
primer
consist
specif
primer
sequenc
fuse
univers
primer
sequenc
primer
design
gener
gene
fragment
length
bp
amount
univers
primer
includ
rtpcr
ten
time
chimer
primer
last
cycl
pcr
amplif
carri
predominantli
singl
pair
univers
primer
forward
univers
primer
label
fluoresc
reduc
occurr
preferenti
amplif
reaction
intern
control
primer
ad
reaction
ascertain
whether
extract
reversetranscript
step
assay
function
correctli
pcr
amplifi
fragment
separ
capillari
electrophoresi
base
size
detect
gexp
system
specif
gexp
assay
examin
use
artifici
specimen
panel
clinic
specimen
confirm
previous
posit
specif
peak
pcr
product
obtain
expect
viral
target
use
gexp
system
crossreact
among
respiratori
viru
typessubtyp
observ
detect
sensit
viru
copi
per
reaction
assay
number
posit
neg
specimen
detect
gexp
assay
indic
gexp
gexp
respect
number
posit
neg
specimen
detect
rvp
fast
assay
indic
rvp
rvp
respect
sensit
true
posit
tp
specif
true
neg
tn
ppv
tptp
fals
posit
npv
tntn
fals
neg
target
calcul
use
rvp
fast
assay
refer
comparison
b
rvp
fast
assay
abl
subtyp
flua
rsv
posit
specimen
c
rvp
fast
assay
abl
distinguish
rhinoviru
enteroviru
hrv
posit
detect
rvp
fast
assay
could
hrv
enteroviru
specimen
posit
hrv
detect
gexp
assay
confirm
sequenc
true
posit
addit
detect
gexp
assay
confirm
sequenc
true
posit
perform
separ
viru
sensit
copi
per
reaction
premix
viral
target
present
multiplex
assay
result
indic
detect
sensit
gexp
assay
mix
viru
sampl
slightli
lower
singl
type
viru
detect
sensit
viru
studi
similar
realtim
pcr
assay
report
recent
year
analys
specimen
use
gexp
assay
rvp
fast
assay
demonstr
gexp
assay
compar
sensit
specif
commerci
avail
rvp
fast
assay
tabl
discrep
detect
result
found
hrv
hmpv
adv
rsv
b
hbov
specimen
posit
hrv
detect
gexp
assay
confirm
independ
pcr
sequenc
true
posit
data
shown
suggest
gexp
assay
sensit
rvp
fast
assay
detect
hrv
hrv
primer
use
rvp
fast
assay
abl
amplifi
hrv
enteroviru
three
specimen
posit
hrv
detect
rvp
fast
assay
could
actual
enterovirus
specimen
posit
hrv
detect
gexp
assay
confirm
sequenc
true
hrv
posit
two
hmpv
neg
sampl
adv
neg
sampl
rsvb
neg
sampl
hbov
neg
sampl
detect
gexp
assay
posit
rvp
fast
assay
neg
sampl
lower
median
floresc
intens
mfi
valu
rvp
fast
assay
suggest
gexp
assay
slightli
decreas
sensit
detect
hmpv
adv
rsvb
hbov
howev
differ
signific
hmpv
adv
rsvb
hbov
p
respect
use
mcnemar
test
kappa
respect
detect
coronavirus
cov
cov
cov
cov
assay
complet
consist
assay
overal
detect
rate
gexp
assay
viru
compar
rvp
fast
assay
demonstr
high
sensit
specif
gexp
assay
analysi
clinic
sampl
note
suffici
posit
sampl
flua
flub
cov
cov
cov
rsva
determin
meaning
statist
studi
due
limit
specimen
avail
time
preliminari
find
report
studi
detect
rate
infect
involv
two
virus
similar
gexp
assay
rvp
fast
assay
occurr
multiplex
infect
involv
two
three
virus
hrv
rsvb
data
shown
two
distinct
advantag
gexp
assay
short
assay
time
low
cost
per
test
though
cost
gexp
equip
approxim
cost
gexp
assay
simultan
detect
respiratori
viru
typessubtyp
approxim
per
test
rtpcr
kit
consum
detect
versu
per
test
use
rvp
fast
kit
per
test
viru
use
commerci
rtpcr
kit
daan
gene
china
whole
reaction
complet
one
tube
onestep
multiplex
rtpcr
within
hour
follow
capillari
electrophoresi
separ
min
well
addit
two
plate
place
parallel
gexp
machin
time
increas
throughput
sampl
summari
studi
demonstr
gexp
assay
rapid
costeffect
high
throughput
method
high
sensit
specif
detect
respiratori
viru
infect
valid
gexp
assay
larger
number
clinic
sampl
necessari
method
use
wide
routin
laboratori
test
china
